A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
PHASE3
This is a parallel group, Phase 3, multinational, multicenter, randomized, ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham- Site Number : 8401267
Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis
PHASE2
to explore the atrophogenic potentials of hydrocortison 1% cream and pimecr...
Status
Completed
Location
Department of Dermatology, Medical Faculty, TU Dresden